Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

Recovery After Laparoscopic Weight Loss Surgery: Study Protocol Sample

Case Report Sample Work

The administration of a neuromuscular blocking agent (NMBA) facilitates patient ventilation during surgery, prevents involuntary movements by the patient and enhances surgical exposure. Rucuronium, an aminosteroid and cisatacurium, a benzylisoquinone compound are two commonly used neuromuscular blocking agents with different molecular and pharmacological properties

From a case study brief to a prospective observational protocol

Although it is filed as a case study, this sample reads as a short research protocol. It sets out the rationale and design for a prospective observational study describing the quality of recovery in patients with severe obesity after laparoscopic bariatric surgery, with particular attention to the anaesthetic drugs used to reverse neuromuscular blockade. Its readers are anaesthetists, bariatric surgical teams, research and development departments and potential sponsors who need to judge whether the study is worth running and how it will be conducted.

The document moves from an introduction and a section titled "Case study process" to a proposed title and objectives, followed by methodology, study population with inclusion and exclusion criteria, study procedures, primary and secondary data collection, statistical methods, administrative and regulatory details, a publications plan and ten references. That sequence follows the logic of a full protocol in condensed form.

Why reversal of neuromuscular blockade matters after bariatric surgery

The introduction explains the clinical background. Patients with severe obesity undergoing laparoscopic bariatric surgery are vulnerable to post-operative complications and need tailored anaesthetic care. Neuromuscular blocking agents facilitate ventilation, prevent involuntary movement and improve surgical exposure; the sample names rocuronium, an aminosteroid, and cisatracurium, a benzylisoquinolinium compound, as two commonly used agents with different pharmacological properties.

At the end of surgery the block must be reversed so that patients can breathe independently. The sample contrasts acetylcholinesterase inhibitors such as neostigmine with sugammadex, an encapsulating agent for aminosteroid blockers, and explains that rapid, reliable reversal helps avoid postoperative residual curarisation, which can cause serious respiratory problems. It cites a randomised controlled trial in laparoscopic surgery in which 94% of patients given sugammadex recovered within five minutes, compared with 20% given neostigmine. The central argument follows: because sugammadex costs more, clinicians and managers need evidence on whether it improves the quality of post-surgical recovery, and with rising numbers of patients with obesity in the UK, surgical departments face pressure to improve efficiency.

Population, data flow and analysis as the protocol specifies them

The proposed title, a prospective study to describe the quality of recovery of morbidly obese patients following laparoscopic bariatric surgery, is paired with three descriptive objectives: the recovery process, the anaesthetic procedures used, and the demographic and clinical characteristics of patients. The design details are concrete:

ElementWhat the sample specifies
Setting and durationOperating suites at three UK hospital sites over three months
Sample120 patients undergoing laparoscopic bariatric surgery
InclusionBMI of 40 kg/m² or above; aged 18 or over at surgery
ExclusionUnavailable medical records; refusal or lack of capacity to consent; contraindication to neuromuscular blocking agents
Data sourcesRetrospective review of notes for diagnosis, medicines and characteristics; prospective collection from induction of anaesthesia to transfer to the ward
Data captureTheatre, recovery and ward staff at the point of care, using paper forms transcribed into an electronic database
AnalysisDescriptive only: means or medians with standard deviations or interquartile ranges, and frequencies and percentages for categorical variables

The protocol also describes written informed consent procedures, criteria for judging whether an adverse event is causally related to a sponsor's product, and the rule that causality must not be assigned retrospectively during secondary data review. Confidentiality sections cover sponsor information and subject records, with patients identified only by unique code.

Protocol conventions behind the document

Several of the sample's sections reflect established expectations for observational research. Clear eligibility criteria, a defined setting and period, a description of data sources and an explicit statistical approach correspond to items that the STROBE statement asks authors to report when the eventual paper is written, so drafting them at protocol stage makes later reporting easier. The consent procedures, which allow patients time to read the information sheet and ask questions, reflect standard research ethics requirements in the NHS. The adverse event and confidentiality language mirrors the clauses sponsors usually require in investigator agreements.

The publications section plans dissemination through conference posters or oral presentations, an end-of-study report for the sponsor and submission to a peer-reviewed journal. Stating this at the outset is good practice, because it sets expectations about authorship and data ownership before the study begins.

Points to sharpen when adapting the protocol

Researchers using this sample as a starting point for their own perioperative study will want to build on it. The objectives are descriptive, so a future version would benefit from naming a validated quality-of-recovery instrument and its timing, defining a primary outcome, and justifying the sample of 120 with a precision or feasibility calculation. If the aim is ultimately to compare sugammadex with neostigmine, the protocol should state how reversal agent choice will be recorded and how confounding by surgical or patient factors will be handled, since an observational design cannot randomise.

Pubrica's experimental design service helps refine objectives and outcome measures at this stage, and biostatistics support can provide the sample size reasoning and analysis plan. Once data are collected, physician manuscript writing can turn the results into a journal article. This page shows a writing sample and is not clinical guidance on anaesthetic practice.

Questions about this sample

Is this sample a case report about an individual patient?

No. Despite the case study label, it is a condensed protocol for a prospective observational study of 120 patients undergoing laparoscopic bariatric surgery at three UK hospital sites. It describes the rationale, objectives, eligibility, data collection and analysis plan rather than one patient's clinical course.

Why does the protocol focus on sugammadex and neostigmine?

Both reverse neuromuscular blockade after surgery, but sugammadex is more expensive. The sample cites evidence of faster recovery with sugammadex and argues that clinicians and managers need data on whether it improves the quality of post-surgical recovery in patients with severe obesity to justify its cost.

What statistical analysis does the sample plan?

All analyses are descriptive. Quantitative variables will be summarised with medians or arithmetic or geometric means and with standard deviations or interquartile ranges; nominal variables with frequencies and percentages; and ordinal variables also with medians and interquartile ranges. No hypothesis testing is proposed.

Who collects the data in the proposed study?

Nominated members of the theatre team, recovery unit team and ward staff collect data at the point of care, which the protocol says is intended to minimise observer bias. Data are recorded on paper forms and then transcribed into an electronic database, with patients identified by unique code.

sample-workimage-for-sidebar

Research your Services with our experts

Delivered on-time or your money back

Give yourself the academic edge today

Each order includes

  • On-time delivery or your money back
  • A fully qualified writer in your subject
  • In-depth proofreading by our Quality Control Team
  • 100% confidentiality, the work is never re-sold or published
  • Standard 7-day amendment period
  • A paper written to the standard ordered
  • A detailed plagiarism report
  • A comprehensive quality report

Enquire Now

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.